Freddie C. Hamdy, MD of University of Oxford discusses the how surgery, radiation, and active surveillance arms of the ProtecT study differ in terms of overall survival and metastasis free patients at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.